Mergers & acquisitions

January 23, 2013, 8:55 PM UTC

Allergan Inc. (NYSE: AGN) has agreed to acquire neurology-focused drugmaker MAP Pharmaceuticals Inc. (Nasdaq: MAPP) for $958 million, or $25 per share (60% premium to yesterday’s closing price)

Bridgepoint has retained JPMorgan to explore strategic options for Swedish dialysis companyDiaverum, according to Reuters. A sale could be valued at more than €1 billion.

Cisco Systems (Nasdaq: CSCO) has agreed to acquire Intucell, an Israel-based provider of self-optimizing software for mobile carriers, for around $475 million in cash. Intucell had raised VC funding from Bessemer Venture

Fleetmatics Group Ltd. (NYSE: FLTX), a provider of fleet management SaaS solutions, has filed for a secondary offering of 7 million shares. The deal would generate nearly $185 million for selling shareholder Investcorp Technology Ventures, based on last Friday’s closing price of $26.41 per share. If completed, the deal would drop Investocorp’s ownership stake from 70.2% to just under

H.J. Heinz Co. (NYSE: HNZ) has made a $60 million earn-out payment to Singapore-based private equity firm Transpac Industrial Holdings, related to Heinz’s November 2010 acquisition of Foodstar, a maker of soy sauces and fermented bean curd in China. The original deal included a $165 million up-front cash payment.

Kamylon Capital has sold its stake in Innovadex LLC, an Overland Park, Kansas-based provider of search tools for product developers in the life sciences and chemical industries, to Underwriters Laboratories. No financial terms were disclosed.

Unilever Ventures and FF&P Private Equity have sold BAC BV, a Dutch developer of affinity ligands and affinity purification products, to Life Technologies Corp. (Nasdaq: LIFE). No financial terms were disclosed.

Yahoo Inc. (Nasdaq: YHOO) has acquired social bookmarking startup for an undisclosed amount. Snip-it had raised VC funding from Charles River Ventures, Khosla Ventures, SV Angel and True Ventures.

Sign up for Dan’s daily email newsletter on deals and deal-makers: